Artificial intelligence-based drug discovery portfolio company Atomwise has closed $123 million in a Series B funding round.

Recursion, a biopharma company combining automated, experimental biology with artificial intelligence to discover and develop drugs at scale, has closed a $121 million Series C financing round.

Mythic has raised $30 million in Series B-1 funding.

Automated cloud security company for AWS, Lacework has closed a $24 million Series B funding round.

San Francisco, California-based foot traffic analytics company Dor has closed a Series A funding round of $8.5 million.